Compare
Gsk vs Sanofi
Gsk (GSK) and Sanofi (SNY) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.
| Gsk GSKNYSE · Pharmaceutical Preparations | Sanofi SNYNASDAQ · Pharmaceutical Preparations | |
|---|---|---|
| Insider records, last 12 months | 0 | 0 |
| Congress trades, last 12 months | 0 | 0 |
| Fund positions reported, last 12 months | 52 | 42 |
| Federal contract awards, last 12 months | 0 | 0 |
| Open-market purchases by insiders since 2006 | 0 | 0 |
| Open-market sales by insiders since 2006 | 0 | 0 |
| Last open-market purchase by an insider | None on record | None on record |
| Next results | Not announced | Not announced |
Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.
Common questions
Which has had more insider buying, Gsk or Sanofi?
Since 2006, insiders of both companies reported 0 open-market purchases, in SEC Forms 4 and 5.
Do members of Congress trade GSK or SNY?
In the last 12 months, members of Congress disclosed 0 trades in Gsk (GSK) and 0 in Sanofi (SNY), each reported as a value range on a periodic transaction report.
When did insiders last buy GSK and SNY?
Gsk: no open-market purchase on record. Sanofi: no open-market purchase on record. Dates are those of the SEC filings.
See the record behind any of these
Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Gsk pageSanofi pageRare insider trades this weekAll comparisons
https://oqro.io/compare/gsk-vs-sny